At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 38 enrolled
Drug / intervention
Methotrexate (MTX)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Exposure, Safety and Local Tolerance Study Comparing 3 Routes of Methotrexate (MTX) Administration: Vibex-MTX Device, Subcutaneous (SC)and Intramuscular (IM) in Adult Subjects With Rheumatoid Arthritis
In Brief
A Phase 2 clinical trial evaluating Methotrexate (MTX) for Rheumatoid Arthritis. Completed, enrolled 38 participants across 1 site.
Detailed Summary
Pharmacokinetics (PK) study
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
Primary CompletionMay 2011
Study CompletionJun 2011
First PostedNov 2012
TodayJul 2026
First PostedNov 30, 2012
Enrollment StartJan 1, 2011
Primary CompletionMay 1, 2011
Study CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 13.6 years ago
Interventions
Methotrexate (MTX)drug
Vibex MTX Device